Treatment options for metastatic hormone-sensitive prostate cancer

被引：3
作者：
Kostos, Louise [1 ]
Murphy, Declan G. [2 ,3 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Urol, Melbourne, Vic, Australia
[3] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 10期
关键词：
D O I：
10.1016/S1470-2045(22)00520-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1234 / 1235
页数：2
相关论文
共 10 条
  • [1] Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
    Armstrong, Andrew J.
    Azad, Arun A.
    Iguchi, Taro
    Szmulewitz, Russell Z.
    Petrylak, Daniel P.
    Holzbeierlein, Jeffrey
    Villers, Arnauld
    Alcaraz, Antonio
    Alekseev, Boris
    Shore, Neal D.
    Gomez-Veiga, Francisco
    Rosbrook, Brad
    Zohren, Fabian
    Yamada, Shunsuke
    Haas, Gabriel P.
    Stenzl, Arnulf
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) : 1616 - +
  • [2] ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
    Armstrong, Andrew J.
    Szmulewitz, Russell Z.
    Petrylak, Daniel P.
    Holzbeierlein, Jeffrey
    Villers, Arnauld
    Azad, Arun
    Alcaraz, Antonio
    Alekseev, Boris
    Iguchi, Taro
    Shore, Neal D.
    Rosbrook, Brad
    Sugg, Jennifer
    Baron, Benoit
    Chen, Lucy
    Stenzl, Arnulf
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (32) : 2974 - +
  • [3] Azad AA, INTERN MED J, V152, P1339
  • [4] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Chi, Kim N.
    Agarwal, Neeraj
    Bjartell, Anders
    Chung, Byung Ha
    Pereira de Santana Gomes, Andrea J.
    Given, Robert
    Juarez Soto, Alvaro
    Merseburger, Axel S.
    Ozguroglu, Mustafa
    Uemura, Hirotsugu
    Ye, Dingwei
    Deprince, Kris
    Naini, Vahid
    Li, Jinhui
    Cheng, Shinta
    Yu, Margaret K.
    Zhang, Ke
    Larsen, Julie S.
    McCarthy, Sharon
    Chowdhury, Simon
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01) : 13 - 24
  • [5] Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
    Davis, Ian D.
    Martin, Andrew J.
    Stockler, Martin R.
    Begbie, Stephen
    Chi, Kim N.
    Chowdhury, Simon
    Coskinas, Xanthi
    Frydenberg, Mark
    Hague, Wendy E.
    Horvath, Lisa G.
    Joshua, Anthony M.
    Lawrence, Nicola J.
    Marx, Gavin
    McCaffrey, John
    McDermott, Ray
    McJannett, Margaret
    North, Scott A.
    Parnis, Francis
    Parulekar, Wendy
    Pook, David W.
    Reaume, M. Neil
    Sandhu, Shahneen K.
    Tan, Alvin
    Tan, T. Hsiang
    Thomson, Alastair
    Tu, Emily
    Vera-Badillo, Francisco
    Williams, Scott G.
    Yip, Sonia
    Zhang, Alison Y.
    Zielinski, Robert R.
    Sweeney, Christopher J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02) : 121 - 131
  • [6] Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 x 2 factorial design
    Fizazi, Karim
    Foulon, Stephanie
    Carles, Joan
    Roubaud, Guilhem
    McDermott, Ray
    Flechon, Aude
    Tombal, Bertrand
    Supiot, Stephane
    Berthold, Dominik
    Ronchin, Philippe
    Kacso, Gabriel
    Gravis, Gwenaelle
    Calabro, Fabio
    Berdah, Jean-Francois
    Hasbini, Ali
    Silva, Marlon
    Thiery-Vuillemin, Antoine
    Latorzeff, Igor
    Mourey, Loic
    Laguerre, Brigitte
    Abadie-Lacourtoisie, Sophie
    Martin, Etienne
    El Kouri, Claude
    Escande, Anne
    Rosello, Alvar
    Magne, Nicolas
    Schlurmann, Friederike
    Priou, Frank
    Chand-Fouche, Marie-Eve
    Freixa, Salvador Villa
    Jamaluddin, Muhammad
    Rieger, Isabelle
    Bossi, Alberto
    [J]. LANCET, 2022, 399 (10336) : 1695 - 1707
  • [7] Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
    Gillessen, Silke
    Armstrong, Andrew
    Attard, Gert
    Beer, Tomasz M.
    Beltran, Himisha
    Bjartell, Anders
    Bossi, Alberto
    Briganti, Alberto
    Bristow, Robert G.
    Bulbul, Muhammad
    Caffo, Orazio
    Chi, Kim N.
    Clarke, Caroline S.
    Clarke, Noel
    Davis, Ian D.
    de Bono, Johann S.
    Duran, Ignacio
    Eeles, Ros
    Efstathiou, Eleni
    Efstathiou, Jason
    Ekeke, Onyeanunam Ngozi
    Evans, Christopher P.
    Fanti, Stefano
    Feng, Felix Y.
    Fizazi, Karim
    Frydenberg, Mark
    George, Dan
    Gleave, Martin
    Halabi, Susan
    Heinrich, Daniel
    Higano, Celesta
    Hofman, Michael S.
    Hussain, Maha
    James, Nick
    Jones, Robert
    Kanesvaran, Ravindran
    Khauli, Raja B.
    Klotz, Laurence
    Leibowitz, Raya
    Logothetis, Chris
    Maluf, Fernando
    Millman, Robin
    Morgans, Alicia K.
    Morris, Michael J.
    Mottet, Nicolas
    Mrabti, Hind
    Murphy, Declan G.
    Murthy, Vedang
    Oh, William K.
    Ost, Piet
    [J]. EUROPEAN UROLOGY, 2022, 82 (01) : 115 - 141
  • [8] Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial
    Gu, Weijie
    Han, Weiqing
    Luo, Hong
    Zhou, Fangjian
    He, Dalin
    Ma, Lulin
    Guo, Hongqian
    Liang, Chaozhao
    Chong, Tie
    Jiang, Jun
    Chen, Zhiwen
    Wang, Yong
    Zou, Qing
    Tian, Ye
    Xiao, Jun
    Huang, Jian
    Zhu, Shaoxing
    Dong, Qiang
    Zhang, Xiaoping
    Li, Hanzhong
    Yang, Xinfeng
    Chen, Chunxia
    Li, Junliang
    Jin, Chunlei
    Zhang, Xiaojing
    Ye, Dingwei
    [J]. LANCET ONCOLOGY, 2022, 23 (10) : 1249 - 1260
  • [9] Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial
    Qin, Xiaojian
    Ji, Dongmei
    Gu, Weijie
    Han, Weiqing
    Luo, Hong
    Du, Chuanjun
    Zou, Qing
    Sun, Zhongquan
    He, Chaohong
    Zhu, Shaoxing
    Chong, Tie
    Yao, Xin
    Wan, Ben
    Yang, Xinfeng
    Bai, Aobing
    Jin, Chunlei
    Zou, Jianjun
    Ye, Dingwei
    [J]. BMC MEDICINE, 2022, 20 (01)
  • [10] Epidemiology and genomics of prostate cancer in Asian men
    Zhu, Yao
    Mo, Miao
    Wei, Yu
    Wu, Junlong
    Pan, Jian
    Freedland, Stephen J.
    Zheng, Ying
    Ye, Dingwei
    [J]. NATURE REVIEWS UROLOGY, 2021, 18 (05) : 282 - 301
1